FDA
-
-
-
-
-
-
-
ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint
-
-
-
-
-
-
-
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026
-
-
-
-
-
-
-
ClearPoint Neuro Reports Third Quarter 2025 Results
-
-
-
-
-
-
-
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
-
-
-
-
-
-
-
ClearPoint Neuro delivers first commercial gene therapy to US brains
-
-
-
-
-
-
-
ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Clearpoint Neuro Inc. (CLPT)
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

